See more : The Aomori Bank, Ltd. (8342.T) Income Statement Analysis – Financial Results
Complete financial analysis of KP Tissue Inc. (KPTSF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of KP Tissue Inc., a leading company in the Household & Personal Products industry within the Consumer Defensive sector.
- Financial Street Property Co., Limited (1502.HK) Income Statement Analysis – Financial Results
- PT Inti Agri Resources Tbk (IIKP.JK) Income Statement Analysis – Financial Results
- PT Sumber Mas Konstruksi Tbk (SMKM.JK) Income Statement Analysis – Financial Results
- Umpqua Holdings Corporation (UMPQ) Income Statement Analysis – Financial Results
- Mercuries Data Systems Ltd. (2427.TW) Income Statement Analysis – Financial Results
KP Tissue Inc. (KPTSF)
Industry: Household & Personal Products
Sector: Consumer Defensive
Website: https://www.kptissueinc.com
About KP Tissue Inc.
KP Tissue Inc., through its interest in Kruger Products L.P., produces, distributes, markets, and sells a range of disposable tissue products in Canada and the United States. The company operates through two segments, Consumer and Away-From-Home. It offers bathroom and facial tissues, paper towels, and napkins, as well as manufactures private label tissue products. The company markets its products under the Cashmere, Purex, SpongeTowels, Scotties, White Swan, White Cloud, Chalet, Embassy, White Swan, and Metro brand names. The company sells its products to consumers through traditional retail channels, such as grocery stores, mass merchandisers, club and drug stores, convenience stores, and online retailers; and through distributors to businesses involved in commercial users in the property management, healthcare, food services, manufacturing, lodging industries, and public facilities. KP Tissue Inc. was incorporated in 2012 and is headquartered in Mississauga, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 830.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Expenses | 0.00 | -752.00K | -321.00K | -634.00K | 574.00K | 196.00K | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 830.00K | -752.00K | -321.00K | -634.00K | 574.00K | 196.00K | 3.25M | 67.00K | 33.41M | 2.28M | 1.73M | 3.96K |
| Cost & Expenses | 830.00K | -752.00K | -321.00K | -634.00K | 574.00K | 196.00K | 3.25M | 67.00K | 33.41M | 2.28M | 1.73M | -3.96K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 11.80M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation & Amortization | 238.61K | 115.99M | 153.43M | 197.84M | 145.04M | 161.14K | 52.52K | 22.82K | 0.00 | 0.00 | 0.00 | 0.00 |
| EBITDA | 238.61K | 115.99M | 153.43M | 197.84M | 145.04M | 0.00 | 0.00 | 0.00 | -33.41M | -2.28M | 1.73M | -2.77K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Operating Income | 0.00 | -752.00K | -321.00K | -634.00K | -574.00K | -196.00K | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | -2.77K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Total Other Income/Expenses | -830.00K | -12.55M | 1.12M | -794.00K | -4.23M | 1.78M | 0.00 | 67.00K | 33.41M | 0.00 | 1.73M | -3.96K |
| Income Before Tax | -830.00K | -12.55M | 1.12M | -794.00K | -4.80M | 1.59M | -3.25M | 67.00K | -33.41M | -2.28M | 1.73M | -3.96K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 0.00% |
| Income Tax Expense | 4.11M | -2.30M | -118.00K | 1.16M | 1.73M | 1.76M | 2.19M | 1.79M | -2.07M | 241.00K | 2.01M | 592.00 |
| Net Income | -4.94K | -10.25M | 1.24M | -1.95M | -6.53M | -173.00K | -5.44M | -1.72M | -31.34M | -2.52M | -285.00K | -3.36K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 167.42% | -2,570.15% | 93.82% | 110.58% | -16.49% | 0.00% |
| EPS | -0.50 | -1.03 | 0.13 | -0.20 | -0.68 | -0.02 | -0.59 | -0.19 | -3.52 | -0.29 | -0.03 | 0.00 |
| EPS Diluted | -0.50 | -1.03 | 0.13 | -0.20 | -0.68 | -0.02 | -0.59 | -0.19 | -3.52 | -0.29 | -0.03 | 0.00 |
| Weighted Avg Shares Out | 9.96M | 9.94M | 9.84M | 9.70M | 9.54M | 9.32M | 9.16M | 9.04M | 8.91M | 8.83M | 8.75M | 8.00M |
| Weighted Avg Shares Out (Dil) | 9.96M | 9.94M | 9.84M | 9.70M | 9.54M | 9.32M | 9.16M | 9.04M | 8.91M | 8.83M | 8.75M | 8.00M |
KP Tissue Inc. Reports on Shareholders' Voting Results for the Election of Directors
REPEAT – KP Tissue Announces its Annual Meeting of Shareholders
KP Tissue Reminds Shareholders to Vote in Advance of Deadline for 2024 Annual Meeting of Shareholders
KP Tissue Announces its Annual Meeting of Shareholders
KP Tissue Inc. (KPTSF) Q1 2024 Earnings Call Transcript
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
KP Tissue Releases First Quarter 2024 Financial Results
KP Tissue Announces Filing and Mailing of the Management Proxy Materials in Connection with its 2024 Annual Meeting of Shareholders
KP Tissue to Release its Financial Results and those of Kruger Products Inc. for the First Quarter of 2024
KP Tissue declares a Quarterly Dividend of $0.18 per Common Share
Source: https://incomestatements.info
Category: Stock Reports